<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01339598</url>
  </required_header>
  <id_info>
    <org_study_id>HREC 11065</org_study_id>
    <nct_id>NCT01339598</nct_id>
  </id_info>
  <brief_title>Remediation of Cognitive Dysfunction in Euthymic Bipolar Disorder Patients Using Transcranial Direct Current Stimulation (tDCS)</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of New South Wales</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of New South Wales</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to investigate the potential for Transcranial Direct Current Stimulation
      (tDCS) to enhance cognitive functioning in euthymic bipolar patients through comparing the
      effect of active or sham tDCS (placebo control) during the performance of two cognitive
      tasks. The investigators hypothesize that task performance will be improved with active
      relative to sham tDCS.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total correct responses.</measure>
    <time_frame>Across each session (approximately 1 hour in duration), with each session conducted at least 1 week apart.</time_frame>
    <description>Total number of correct responses on each task in each session.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Bipolar Disorder</condition>
  <arm_group>
    <arm_group_label>Sham transcranial direct current stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Transcranial direct current stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Different transcranial direct current stimulation montage</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial direct current stimulation (Eldith DC Stimulator)</intervention_name>
    <description>Eldith DC Stimulator (NeuroConn GmbH, Germany)</description>
    <arm_group_label>Sham transcranial direct current stimulation</arm_group_label>
    <arm_group_label>Transcranial direct current stimulation</arm_group_label>
    <arm_group_label>Different transcranial direct current stimulation montage</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participants will be right-handed subjects aged 18-65 meeting DSM-IV diagnostic
             criteria for bipolar disorder, with no acute episodes of depression or mania within
             the previous 12 weeks

          -  A score of ≤ 20 on the MADRS, and a score of ≤ 6 on the YMRS, who have been on a
             stable dose of mood stabiliser medications for at least 1 month.

        Exclusion Criteria:

          -  Patients with high suicide risk

          -  Co-morbid DSM-IV diagnosis of any psychotic disorder (current or within the last
             year), schizophrenia and schizoaffective disorder

          -  Mental retardation

          -  A history of drug or alcohol abuse or dependence within the last 3 months

          -  Co-morbid attention deficit hyperactivity disorder (ADHD), or any neurological
             disorder

          -  Recent stroke

          -  Head injury

          -  History of seizure, or who have had electroconvulsive therapy (ECT) within the 6
             months preceding enrolment.

          -  Participants will also be excluded if currently taking medications known to be
             associated with frank cognitive impairment (e.g., benzodiazepines).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of New South Wales</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <zip>2031</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 7, 2011</study_first_submitted>
  <study_first_submitted_qc>April 19, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 20, 2011</study_first_posted>
  <last_update_submitted>November 2, 2015</last_update_submitted>
  <last_update_submitted_qc>November 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 3, 2015</last_update_posted>
  <responsible_party>
    <name_title>Dr Donel Martin</name_title>
    <organization>University of New South Wales</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bipolar Disorder</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

